A group of Canadian undergrads is using plants to revolutionize medicine. Faced with soaring drug prices and global shortages ...

Novo Nordisk, the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

The Food and Drug Administration wants bulk production of the copycats to stop—starting Wednesday for pharmacy-prepared versions of Zepbound and later in the spring for knockoffs of Ozempic and ...

Ozempic, Wegovy sales have soared in recent years Shortages and insurance coverage have made it difficult to get The naturally occurring molecule shows promise in suppressing appetite Ozempic ...

Two studies suggested the diabetes/weight-loss drug may have a beneficial side effect—but more work is needed to confirm this.

And it puts Ozempic’s $1,000-a-month bill to shame, costing just a few bucks at supermarkets and on Amazon. Yerba maté is a plant native to southern parts of South America, including Paraguay ...

Shares of Novo Nordisk A/S were getting hit hard Monday, after the maker of Ozempic and Wegovy, the diabetes and obesity treatments, revealed data showing that its new weight-loss drug candidate ...

Insurance for weight-loss drugs like Ozempic is shaping up as the next power struggle between employers and employees. Some companies have curbed or ended coverage for blockbuster weight-loss ...

This triggers insulin production and helps regulate your blood sugar. The active ingredient in Ozempic, semaglutide, is not a controlled substance and typically not part of a drug screening test.